Cargando…

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial

Aims: Bioactive adrenomedullin (bio-ADM) was recently shown to be a prognostic marker in patients with acute circulatory failure. We investigate the association of bio-ADM with organ injury, functional impairment, and survival in cardiogenic shock (CS). Methods: OptimaCC was a multicenter and random...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagi, Koji, Levy, Bruno, Kimmoun, Antoine, Miró, Òscar, Duarte, Kévin, Asakage, Ayu, Blet, Alice, Deniau, Benjamin, Schulte, Janin, Hartmann, Oliver, Cotter, Gad, Davison, Beth A, Gayat, Etienne, Mebazaa, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509471/ https://www.ncbi.nlm.nih.gov/pubmed/34640526 http://dx.doi.org/10.3390/jcm10194512

Ejemplares similares

Plasma and Urinary Biomarkers Improve Prediction of Mortality through 1 Year in Intensive Care Patients: An Analysis from FROG-ICU
por: Davison, Beth A., et al.
Publicado: (2023)

Predictive Performance of Neutrophil Gelatinase Associated Lipocalin, Liver Type Fatty Acid Binding Protein, and Cystatin C for Acute Kidney Injury and Mortality in Severely Ill Patients
por: Asakage, Ayu, et al.
Publicado: (2024)

Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
por: Blet, Alice, et al.
Publicado: (2019)

Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU
por: Blet, Alice, et al.
Publicado: (2020)

Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
por: Tolppanen, Heli, et al.
Publicado: (2017)

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
por: Mebazaa, Alexandre, et al.
Publicado: (2018)

Systemic Inflammation Evaluated by Interleukin-6 or C-Reactive Protein in Critically Ill Patients: Results From the FROG-ICU Study
por: Picod, Adrien, et al.
Publicado: (2022)

Effect of systemic corticosteroid therapy for acute heart failure patients with elevated C‐reactive protein
por: Miró, Òscar, et al.
Publicado: (2022)

Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors
por: Blet, Alice, et al.
Publicado: (2022)

Analysis of blood culture in a rat model of cecal ligation and puncture induced sepsis
por: Vaittinada Ayar, Prabakar, et al.
Publicado: (2020)

Bioactive adrenomedullin for assessment of venous congestion in heart failure
por: Egerstedt, Anna, et al.
Publicado: (2022)

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC)
por: Metra, Marco, et al.
Publicado: (2022)

Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery
por: Hill, Aileen, et al.
Publicado: (2023)

Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study
por: Bronton, Kevin, et al.
Publicado: (2021)

Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research
por: Cotter, Gad, et al.
Publicado: (2021)

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study
por: van Lier, Dirk, et al.
Publicado: (2023)

Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care
por: Lundberg, Oscar H. M., et al.
Publicado: (2022)

Management of Acute Heart Failure during an Early Phase
por: Takagi, Koji, et al.
Publicado: (2020)

Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)
por: Legrand, Matthieu, et al.
Publicado: (2019)

Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
por: Lundberg, Oscar H. M., et al.
Publicado: (2020)

Decisiones optimas financieras
por: Robicheck, Alexander
Publicado: (1972)

Decisiones óptimas financieras /
por: Robichek, Alexander A.
Publicado: (1968)

Kwaliteiten optimaal benutten
por: STALPERS, DEWI
Publicado: (2021)

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
por: Geven, Christopher, et al.
Publicado: (2019)

Fuerza óptima : ¿mito o realidad? /
por: Román Suárez, Iván
Publicado: (2006)

Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure
por: Kozhuharov, Nikola, et al.
Publicado: (2021)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Global differences in acute heart failure treatment: analysis of the STRONG‐HF site feasibility questionnaire
por: Novosadova, Maria, et al.
Publicado: (2023)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary syndrome
por: Arrigo, Mattia, et al.
Publicado: (2019)

Optima and equilibria: an introduction to nonlinear analysis
por: Aubin, Jean-Pierre
Publicado: (1998)

Wear and Friction of UHMWPE-on-PEEK OPTIMA™
por: Cowie, Raelene M., et al.
Publicado: (2019)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

La desilusión óptima del amor : cuentos /
por: Rascón Castro, Cristina, 1976-
Publicado: (2023)

Adrenomedullin and tumour angiogenesis
por: Nikitenko, L L, et al.
Publicado: (2006)

Adrenomedullin and tumour microenvironment
por: Larráyoz, Ignacio M, et al.
Publicado: (2014)

Adrenomedullin and cardiovascular diseases
por: Wong, Hoi Kin, et al.
Publicado: (2012)

Searching for an ideal hemodynamic marker to predict short-term outcome in cardiogenic shock
por: Yilmaz, Mehmet Birhan, et al.
Publicado: (2009)

La desilusión óptima del amor: cuentos
por: Rascón, Cristina
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tkg227qfg2rom9gfilhjs4a8l9